Fighting off pain with resolvins.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Inflammation and Infection in Pain and the Role of GPR37.International journal of molecular sciences · 2022
   Review
2. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?International journal of molecular sciences · 2021
   Review
3. GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain.The Journal of clinical investigation · 2018
   Article
4. Emerging targets in neuroinflammation-driven chronic pain.Nature reviews. Drug discovery · 2014
   Review
5. Body mass index and musculoskeletal pain: is there a connection?Chiropractic & manual therapies · 2013
   Article
6. Microglial-neuronal interactions during neurodegenerative diseases.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2013
   Article
7. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
   Article
8. Emerging roles of resolvins in the resolution of inflammation and pain.Trends in neurosciences · 2011
   Review
9. Resolving TRPV1- and TNF-α-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
   Article
10. Resolvins are potent analgesics for arthritic pain.British journal of pharmacology · 2011
    Article
11. The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats.British journal of pharmacology · 2011
    Article

Corrections and comments

• Comment on
  Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions.2010

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as